Related Experiment Video
Updated: Oct 1, 2026
Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
Beyond the Pediatric end-stage liver disease system: solutions for infants with biliary atresia requiring liver
Mary Elizabeth M Tessier1, Sanjiv Harpavat1, Ross W Shepherd1
1Mary Elizabeth M Tessier, Sanjiv Harpavat, Ross W Shepherd, Girish S Hiremath, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, United States.
Insights
Biliary atresia (BA) is a leading cause of pediatric liver transplants. This review explores optimizing the Kasai operation and expediting transplants to improve outcomes for children with BA.
Area of Science:
- Pediatric Gastroenterology and Hepatology
- Transplantation Medicine
- Infant Liver Disease
Background:
- Biliary atresia (BA) is a progressive cholestatic liver disease in infants.
- It is the primary indication for pediatric liver transplantation, particularly in children under two.
- Current transplant systems pose risks for timely organ access in BA patients.
Purpose of the Study:
- To review strategies for managing children with biliary atresia.
- To explore methods to prevent or delay the need for liver transplantation.
- To examine approaches for expediting liver transplantation when necessary.
Main Methods:
- Review of current literature on biliary atresia management.
- Analysis of the Kasai portoenterostomy's efficacy and optimization.
- Discussion of alternative transplantation techniques beyond standard deceased-donor, ABO-matched organs.
Main Results:
- The Kasai portoenterostomy can be optimized to potentially delay or prevent transplant needs.
- Alternative transplant strategies, such as non-standard deceased-donor or ABO-matched organs, are being explored.
- Challenges remain in ensuring timely and safe liver allocation for pediatric BA patients.
Conclusions:
- Optimizing the Kasai operation is crucial for improving outcomes in biliary atresia.
- Innovative transplantation approaches are needed to address the limitations of current systems.
- Improving access to timely liver transplants is essential for children with BA.
Abstract:
Biliary atresia (BA), a chronic progressive cholestatic disease of infants, is the leading cause for liver transplant in children, especially in patients under two years of age. BA can be successfully treated with the Kasai portoenterostomy; however most patients still require a liver transplant, with up to one half of BA children needing a transplant by age two. In the current pediatric end-stage liver disease system, children with BA face the risk of not receiving a liver in a safe and timely manner. In this review, we discuss a number of possible solutions to help these children. We focus on two general approaches: (1) preventing/delaying need for transplantation, by optimizing the success of the Kasai operation; and (2) expediting transplantation when needed, by performing techniques other than the standard deceased-donor, whole, ABO-matched organ transplant.
